Massive Pulmonary Embolism: Trial of Non-immunogenic Recombinant Staphylokinase VS Alteplase FORPE

NCT04688320 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

310

Enrollment

INDUSTRY

Sponsor class

Conditions

Massive Pulmonary Embolism

Interventions

DRUG: Recombinant nonimmunogenic staphylokinase
DRUG: Alteplase

Sponsor

Supergene, LLC